News  |  Careers  |  Investors

For Clinicians

Clinical DataRenovoCath IFU

Studies continue to support the therapeutic method of the RenovoTAMP platform for targeted treatment of pancreatic cancer. Following are highlights of clinical data from publications, abstracts, and medical conference presentations.*

Trans-arterial Treatment Option in Pancreas Cancer. Presented at 2022 SPECTRUM Conference, January 14-16, 2022

RenovoRx Announces Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual Meeting. Presented at Pancreas Club 2021, November 11-12, 2021

Potential Future Innovative Strategy for Pancreatic Cancer: Intra Arterial Chemotherapy. Presented at Miami Cancer Institute’s New Advances in the Management of Pancreatic Cancer, November 9, 2021

Validating and Optimizing Trans Arterial Micro Perfusion Using a Novel Double Balloon Catheter in a Pig Model for Local Delivery of Chemotherapy to Solid Tumors. Presented at SIR 2021 Annual Scientific Meeting, March 20-26,2021

Sepsis and pancreatic cancer: Biliary stents a significant risk factor in patients undergoing chemotherapy. Presented at 2021 ASCO Gastrointestinal Cancers Symposium , January 15-17, 2021

Resection rate of locally advanced pancreatic cancer in gemcitabine plus nab-paclitaxel versus FOLFIRINOX. Presented at 2021 ASCO Gastrointestinal Cancers Symposium , January 15-17, 2021

Trans Arterial Chemotherapy for Treatment of Locally Advanced Pancreatic Cancer: Treatment Factors Impacting Survival. Presented at SIR 2020 Virtual , June 13-14, 2020

Targeted Intra-Arterial Gemcitabine: Impact on Survival in Patients with Locally Advanced Pancreatic Cancer –A New Treatment Paradigm. Presented at the World Congress on Pancreatic Cancer & Liver Diseases , October 23, 2019

Injection directly into tumor ball

Management of Advanced Stage Hepatocellular Carcinoma with Extensive Portal Vein Tumor Thrombus Using an Adjustable Dual Balloon Occlusion Technique. Published in Journal of Vascular and Interventional Radiology , July, 2019

Localized Intra-arterial Gemcitabine: Impact on Survival in Patients with LAPC – a New Treatment Paradigm. Presented at Pancreas Club Annual Meeting, May 18, 2019

New Experience with Transarterial Micro-Perfusion (TAMP). Presented at GEST 2019, May 11, 2019

Treatment of Hepatic Tumors with Inaccessible Vasculature Using an Adjustable Length Dual Occlusion Balloon Catheter System. Journal of Vascular & Interventional Radiology, September 2018

Injection directly into tumor ball

Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma. Journal of Pancreatic Cancer, August 2017

Intra-arterial Targeted Delivery of Gemcitabine in Treatment of Patients with Loco-regional Pancreatic Tumors. Presented at AHPBA Annual Meeting, April 2, 2017

Treatment of Hepatic Tumors with Inaccessible Vasculature Using an Adjustable Length Dual Occlusion

Pancreatic Cancer: Chemoembolization Using A Double Balloon Catheter. Presented at AIM Symposium, November 14, 2016

Intra-arterial Targeted Delivery of Gemcitabine in Treatment of Patients with Loco-regional Pancreatic Tumors. Poster presented to 50th Annual Pancreas Club Meeting, May 20-21, 2016

Pancreas Club Abstract: Is Intra-Arterial with Targeted Delivery of Gemcitabine Safe in Treatment of Patients with Loco-Regional Pancreatic Tumors? May 20-21, 2016

IHPBA 2016 Abstract: Intra-arterial and Tumor-Targeted Infusion of Gemcitabine in Patients with Unresectable Pancreatic Cancer, April 20-23, 2016

* RenovoTAMP is currently under investigation in the United States.

Menu